About Torigen's autologous prescription product
Millions of animals are diagnosed with cancer each year, yet limited options exist to pet parents aside from chemotherapy and radiation therapy. Even though 50% of dogs over the age of 10 will die from cancer, 90% of these dogs will never see an oncologist.
Advantages of Torigen’s immunotherapy
Patient specific
Treatment uses the patient’s tumor as the antigen source.
Outpatient treatment
Can be administered in any clinical setting and does not require specialized training or equipment.
Convenience
Treatment protocol consists of a subcutaneous injection given as weekly doses (3 for dogs & cats, 6 for horses).
Simple process:
Torigen can coordinate histopathology through our preferred vendor or the provider of your choice.
Submission of tumor samples does not require a financial commitment beyond histopathology unless production of our immunotherapeutic is requested.
This form of cancer immunotherapy may be appropriate for any solid tumor.
Ready to learn more?
Sign up for an informational Lunch-and-Learn session (virtual or in-person) with our team to learn more about how our individualized cancer immunotherapy can be incorporated into your veterinary practice.
After your Lunch and Learn, we are here to help with a brief onboarding training to get you comfortable sending tumors to Torigen by walking you through the submission process.
With your onboarding training, you’ll receive a Starter Pack, which will include:
- 5 tumor submission pouches
- Pet Owner brochures
- Lumps & Bumps brochures
- Price sheet
And more!